HBV-IN-39-d3, CAS 2173356-23-3

HBV-IN-39-d3, CAS 2173356-23-3
Artikelnummer
MEXHY-156703S-1
Verpackungseinheit
1 mg
Hersteller
MedChemExpress

Verfügbarkeit: wird geladen...
Preis wird geladen...
Product Description: HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1].

Applications: COVID-19-anti-virus

Formula: C23H25D3FNO6

References: [1]Yi Chen, et al. Therapeutic agents for the treatment of HBV infection. Patent CN110240596B.

CAS Number: 2173356-23-3

Molecular Weight: 436.49

Research Area: Infection

Solubility: 10 mM in DMSO

Target: HBV
Mehr Informationen
Artikelnummer MEXHY-156703S-1
Hersteller MedChemExpress
Hersteller Artikelnummer HY-156703S-1
Verpackungseinheit 1 mg
Mengeneinheit STK
Produktinformation (PDF) Download
MSDS (PDF)
×